News Archive
-
VIDO-InterVac-led research team at USask awarded almost $1M to fight new coronavirus
Researchers and collaborating scientists from across the country have been awarded almost $1 million over two years to develop animal models and test vaccine candidates for effectiveness and safety against the new coronavirus.
-
Canadian scientists first to test novel diagnostic tool for TB in bison
To help protect Canada’s cattle and bison and maintain the country’s bovine tuberculosis-free status, scientists are conducting trials in bison of several diagnostic tools, including the Actiphage® blood test developed by PBD Biotech.
-
VIDO-InterVac approved to work on SARS-CoV-2
Researchers have received permission from the Public Health Agency of Canada to start working on a vaccine for the coronavirus recently discovered in China, and they hope to have first candidates for testing in an animal model in six to eight weeks.
-
Increasing Canada’s Preparedness for African swine fever with the University of Saskatchewan’s VIDO-InterVac
VIDO-InterVac is the first non-government facility in Canada to work with the ASF virus